Private aTyr raises $59m to target autoimmune diseases
San Diego-based aTyr Pharma raised $49 million in Series D equity financing and secured a $10 million loan to support clinical development of therapeutics for autoimmune diseases.
San Diego-based aTyr Pharma raised $49 million in Series D equity financing and secured a $10 million loan to support clinical development of therapeutics for autoimmune diseases.